Article Details
Retrieved on: 2018-01-08 10:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its position in shares of Sucampo Pharmaceuticals by 13.0% in the second quarter. <b>Vanguard Group</b> Inc. now owns 1,646,348 shares of the biopharmaceutical company's stock valued at $17,287,000 after buying an additional 189,561 shares in the last quarter. Finally ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here